Health Trials

Refractory Peripheral T-Cell Lymphomas

1

Review clinical trials related to Refractory Peripheral T-Cell Lymphomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

This is a multicenter prospective single arm phase II study. The purpose of this study is to evaluate the safety and efficiency of azacytidine combined with CAOLD Regimen in the treatment of relapsed/refractory peripheral t-cell lymphomas.

Participants needed: 52
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Navy General Hospital, BeijingUpdated: Oct 29, 2024Locations: 1
Eligibility criteria

Pathologically confirmed angioimmunoblastic T-cell lymphoma according World Heal... [+8]

Active or uncontrolled infections requiring systemic treatment within 14 days be... [+2]

Read more